RTM
LIVE

Serial Number

79277036

Owner

Neurimmune Holding AG

Attorney

Janice Housey

Filing Date

Dec 12, 2019

Add to watchlist:

No watchlists yet
View on USPTO

RTM Trademark

Serial Number: 79277036 • Registration: 6155830

RTM is a trademark filed by Neurimmune Holding AG on December 12, 2019. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

Neurimmune Holding AG (16 trademarks)

Wagistrasse 18

Entity Type: 25

Trademark Details

Filing Date

December 12, 2019

Registration Date

September 22, 2020

Published for Opposition

July 7, 2020

Goods & Services

Pharmaceutical preparations for the treatment of nervous system diseases, infectious diseases, neoplasms, immune system diseases, endocrine and metabolic diseases, circulatory system diseases, eye diseases; Veterinary preparations for the treatment of nervous system diseases, infectious diseases, neoplasms, immune system diseases, endocrine diseases, metabolic diseases, circulatory system diseases, eye diseases; Pharmaceutical preparations for immunotherapeutic use, pharmaceutical agents for the elimination of tumors, pharmaceutical preparations for the treatment of neurodegenerative diseases, pharmaceutical preparations, namely, immunogens; Pharmaceutical preparations, namely, antibodies used for the testing of the disease; Vaccines; Diagnostic preparations for medical use in the form of epitopes for detecting protein abnormalities; Pharmaceutical preparations, namely, synthetic peptides used for the treatment of central nervous system diseases, metabolic diseases, cardiovascular diseases, cancer, psychiatric diseases, infections; Hygiene preparations for medical use, namely, disinfectants; Biocides; Diagnostic preparations for medical or veterinary use; Sanitary towels for hygiene purposes; Dietetic foods for medical use; Dietetic beverages for medical use; Biological preparations for medical use in the form of protein antibodies directed against specific protein epitopes for use in the treatment of central nervous system diseases, metabolic diseases, cardiovascular diseases, cancer, psychiatric diseases, infections, immunological diseases, inflammatory diseases, respiratory diseases, psychological diseases; Anti-bacterial preparations, namely, anti-bacterial substances for medical use, anti-bacterial pharmaceutical preparations, bio-pharmaceutical preparations for the treatment of cancer; Protein dietary supplements

Medical services; Medical services in the field of immunity; Provision of medical information; Medical examinations, namely, physical examinations for medical purposes; Pharmaceutical consulting in the manufacture of medicines; Services provided by consultants in nutrition and dietetics; Consultancy and providing of information in the field of sanitary care, namely, providing of health information in connection with health; Veterinary services; Beauty salon services; Animal care services, namely, veterinary care services; Medical consulting services for hygiene in the field of care; Medical consultancy and providing of medical information with respect to preparation, administration and dosing of pharmaceutical preparations; Consulting services with respect to preparation and administration of pharmaceutical products; Providing medical information for medical staff and for patients in the form of compiled reports in the field of diagnostic, prophylactic and therapeutic properties of medicines; Drug testing, namely, systematic testing of medicinal products for medical use

Monitoring, inspection and analysis of biologically active chemicals for quality control purposes; Research in the field of pharmaceutical products, cosmetics and foodstuffs for others; Advisory and information services in the field of monitoring and control for purposes of quality control and analysis of biologically active chemicals; Research in the field of medical treatment and medical methods; Research in the field of biotechnology and antibodies; Medical and scientific research in the field of clinical trial review and research with regard to medical treatment; Research in the field of sanitary care; Monitoring and inspection of biological synthesis and pharmaceutical production for quality control purposes and for purposes of scientific research and research in the field of biology; Software design; Computer programming; Maintenance of software; Design and development of computer hardware; Software development; Consultancy and providing of information with respect to quality control of pharmaceutical products; Scientific research in the field of cancerous diseases; Scientific research with respect to chemistry

Filing History

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Sep 22, 2025 REM3
TEAS CHANGE OF CORRESPONDENCE RECEIVED
May 12, 2025 TCCA
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
May 12, 2025 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
May 12, 2025 COAR
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Nov 10, 2023 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Nov 10, 2023 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Nov 10, 2023 REAP
CHANGE OF NAME/ADDRESS REC'D FROM IB
Mar 4, 2022 ADCH
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jul 21, 2021 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Jul 21, 2021 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jul 21, 2021 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jul 21, 2021 REAP
FINAL DECISION TRANSACTION PROCESSED BY IB
Jan 23, 2021 FINV
FINAL DISPOSITION NOTICE SENT TO IB
Jan 1, 2021 FICS
FINAL DISPOSITION PROCESSED
Jan 1, 2021 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Dec 22, 2020 FICR
REGISTERED-PRINCIPAL REGISTER
Sep 22, 2020 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jul 7, 2020 NPUB
PUBLISHED FOR OPPOSITION
Jul 7, 2020 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jun 17, 2020 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 1, 2020 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
May 30, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 29, 2020 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
May 29, 2020 TROA
REFUSAL PROCESSED BY IB
Apr 17, 2020 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Mar 28, 2020 RFCS
REFUSAL PROCESSED BY MPU
Mar 27, 2020 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Mar 13, 2020 RFCR
NON-FINAL ACTION WRITTEN
Mar 12, 2020 CNRT
ASSIGNED TO EXAMINER
Mar 4, 2020 DOCK
APPLICATION FILING RECEIPT MAILED
Feb 1, 2020 MAFR
NEW REPRESENTATIVE AT IB RECEIVED
Jan 31, 2020 NREP
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 28, 2020 NWOS
SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
Jan 23, 2020 SDRC